News

Jacifusen was generally well tolerated and reversed disease progression in some people with ALS caused by mutations in the ...
Transposon said its oral small molecule TPN-101 has been selected for testing as part of the HEALEY ALS platform trial.
Everyone has spaces that bring peace, and life with ALS doesn't change that, writes columnist Juliet Taylor, who shares her ...
Antidepressants that inhibit REM sleep are associated with prolonged survival in people with amyotrophic lateral sclerosis, a ...
After auditing her daily schedule to improve productivity, columnist Dagmar Munn realizes that her time is actually well spent.
Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.
ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...
Living in the moment takes a lot of practice. ALS makes the past a place to visit for short periods of time, but dwelling on the future for too long can create an unbearable fear. That’s why it’s so ...
On June 2, supporters across the U.S. will recognize the legacy of legendary baseball player Lou Gehrig and his impact on ALS ...
Patients with less neuronal damage, determined by low spinal fluid pNFH, had a 48% reduction in the risk of death by adding ...
What does coping mean in life? Columnist Kristin Neva mulls it over after she and her husband with ALS take a mental health survey.
The FDA has cleared Brainstorm to initiate a Phase 3b clinical trial testing NurOwn (debamestrocel) in people with moderate ALS.